Caribou Biosciences, Inc. (CRBU) vs Unicycive Therapeutics, Inc. (UNCY)
A side-by-side comparison of Caribou Biosciences, Inc. and Unicycive Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRBU
Caribou Biosciences, Inc.
$1.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
UNCY
Unicycive Therapeutics, Inc.
$4.23HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CRBU vs UNCY
growth of $100 · dividends reinvested · last 5yCRBU -92.7% (-40.8%/yr)UNCY -84.7% (-31.3%/yr)UNCY compounded faster over this window
CRBU UNCY
CRBU vs UNCY: by the numbers
- •UNCY is the larger company ($113M vs $113M market cap).
- •Both run net losses; UNCY's is the smaller (0.00% vs -1030.42% net margin).
Metrics side by side
Valuation
| Metric | CRBU | UNCY |
|---|---|---|
| P/S ratio | 11.22 | N/A |
| P/B ratio | 1.15 | 2.12 |
Profitability
| Metric | CRBU | UNCY |
|---|---|---|
| Gross margin | 67.34% | 0.00% |
| Operating margin | -1220.49% | 0.00% |
| Net margin | -1030.42% | 0.00% |
| ROE | -105.40% | -66.12% |
| ROIC | -87.72% | -62.15% |
Growth (annualized)
| Metric | CRBU | UNCY |
|---|---|---|
| Revenue CAGR (5Y) | -2.03% | N/A |
| Total return CAGR (5Y) | -44.43% | -32.14% |
Frequently asked
- How have CRBU and UNCY total returns compared?
- Over the past 5 years, CRBU delivered -44.43% and UNCY delivered -32.14% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.